Both in Diagnostics
Myriad Genetics vs Neogen
Over the past year MYGN returned −27.0% and NEOG returned +100.5%; their daily moves had a correlation of 0.16.
MYGN −27.0% NEOG +100.5%Growth of $1, one year, split-adjusted
| Metric | MYGN | NEOG |
|---|---|---|
| Price | $5.97 | $12.61 |
| Market cap | $571.0M | $2.75B |
| Today | −1.16% | +4.21% |
| 1 month | +39.5% | +5.4% |
| 6 months | +45.3% | +37.4% |
| Year to date | −2.9% | +80.4% |
| 1 year | −27.0% | +100.5% |
| Revenue growth (YoY) | −10.5% | +6.5% |
| Gross margin | 66.6% | 47.4% |
| Net margin | −22.7% | −5.3% |
| P/E (TTM) | — | — |
| Price / sales | 0.7× | 3.1× |
| Net cash | -$5.5M | -$605.6M |
| Dividend yield | — | — |
| Volatility (60d) | 85.1% | 42.6% |
| Short % of float | 10.1% | 5.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).